- Home
- SPTN vs ORIC Comparison
SPTN vs ORIC Comparison
Compare SPTN & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPTN
- ORIC
- Stock Information
- Founded
- SPTN 1917
- ORIC 2014
- Country
- SPTN United States
- ORIC United States
- Employees
- SPTN N/A
- ORIC N/A
- Industry
- SPTN Food Distributors
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- SPTN Consumer Discretionary
- ORIC Health Care
- Exchange
- SPTN Nasdaq
- ORIC Nasdaq
- Market Cap
- SPTN 618.4M
- ORIC 633.7M
- IPO Year
- SPTN N/A
- ORIC 2020
- Fundamental
- Price
- SPTN $17.92
- ORIC $10.33
- Analyst Decision
- SPTN Hold
- ORIC Strong Buy
- Analyst Count
- SPTN 1
- ORIC 9
- Target Price
- SPTN $20.00
- ORIC $18.75
- AVG Volume (30 Days)
- SPTN 264.2K
- ORIC 601.8K
- Earning Date
- SPTN 02-13-2025
- ORIC 03-10-2025
- Dividend Yield
- SPTN 4.86%
- ORIC N/A
- EPS Growth
- SPTN 9.92
- ORIC N/A
- EPS
- SPTN 1.33
- ORIC N/A
- Revenue
- SPTN $9,532,883,000.00
- ORIC N/A
- Revenue This Year
- SPTN N/A
- ORIC N/A
- Revenue Next Year
- SPTN $2.15
- ORIC N/A
- P/E Ratio
- SPTN $13.48
- ORIC N/A
- Revenue Growth
- SPTN N/A
- ORIC N/A
- 52 Week Low
- SPTN $17.30
- ORIC $6.33
- 52 Week High
- SPTN $23.00
- ORIC $16.65
- Technical
- Relative Strength Index (RSI)
- SPTN 43.03
- ORIC 59.58
- Support Level
- SPTN $17.68
- ORIC $9.69
- Resistance Level
- SPTN $18.38
- ORIC $11.15
- Average True Range (ATR)
- SPTN 0.38
- ORIC 0.82
- MACD
- SPTN 0.04
- ORIC 0.18
- Stochastic Oscillator
- SPTN 57.41
- ORIC 75.08
About SPTN SpartanNash Company
SpartanNash Co is a food solutions company that delivers the ingredients. Its principal business activities include, distributing grocery products to a diverse group of independent and chain retailers, its corporate-owned retail stores, and U.S. military commissaries and exchanges; as well as operating a fresh produce distribution network and the Our Family private label brand. The company operates in two segments: Retail and Wholesale. Majority of the revenue is earned from its Wholesale segment which uses a multi-channel sales approach to distribute national brand and private brand products to independent retailers, national accounts, food service distributors, e-commerce providers, and the Company's corporate owned retail stores.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.